DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
Hims & Hers Health Inc. (ticker: HIMS) has demonstrated strong revenue growth and market performance in 2025, with a year-to-date gain of 181.9%. The company's growth is supported by the telehealth sector's compound annual growth rate (CAGR) of 25%. HIMS has outperformed its competitor, $DOCS, in a recent analysis of high-stakes stock duels focused on long-term growth. Short interest data for HIMS showed an increase since April 30 but a decline since May 15, indicating fluctuating investor sentiment. The stock's upward momentum aligns with the broader telehealth industry's expansion and investor confidence in HIMS's business model.
